Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week ...

No matter how you get Zepbound ... Food and Drug Administration. Zepbound label. Eli Lilly. How much should I expect to pay for Zepbound (tirzepatide)?. Food and Drug Administration.

No, this isn’t some ... but is often prescribed off-label for weight loss. Your insurance might even cover it differently, potentially saving you money. Zepbound represents a genuine shift ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

Caissa Troutman, MD, recently treated a patient in her early 50s who she planned to prescribe the anti-obesity medication Zepbound ... “morbid obesity” is no longer acceptable and is not ...